DKC1: a robust prognostic factor and potential therapeutic target in multiple myeloma - PubMed
5 hours ago
- #DKC1
- #Therapeutic Target
- #Multiple Myeloma
- DKC1 is identified as a robust prognostic factor and potential therapeutic target in multiple myeloma.
- The study involves human samples and animal experiments approved by the Ethics Committee of the Second Qilu Hospital of Shandong University.
- Keywords associated with the study include ATF5, Apoptosis, DKC1, Multiple myeloma, Prognosis, Proliferation, and Pseudouridylation.
- The authors declare no conflict of interest and have agreed to publish the manuscript.
- References include studies on multiple myeloma incidence, diagnostic criteria, high-risk identification, and causes of drug resistance.